Rossing P - Search Results

1

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis.

Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R; FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, et al. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. Diabetes Care. 2022. PMID: 35972218 Free PMC article. Clinical Trial.

2

Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH. Nielsen FS, et al. Among authors: rossing p. Diabetes. 1994 Sep;43(9):1108-13. doi: 10.2337/diab.43.9.1108. Diabetes. 1994. PMID: 8070610 Clinical Trial.

3

Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.

Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH. Tarnow L, et al. Among authors: rossing p. Diabetes Care. 1996 Dec;19(12):1382-7. doi: 10.2337/diacare.19.12.1382. Diabetes Care. 1996. PMID: 8941468

4

Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.

Nielsen FS, Rossing P, Gall MA, Skøtt P, Smidt UM, Parving HH. Nielsen FS, et al. Among authors: rossing p. Diabetes. 1997 Jul;46(7):1182-8. doi: 10.2337/diab.46.7.1182. Diabetes. 1997. PMID: 9200654 Clinical Trial.

5

Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study.

Parving HH, Tarnow L, Nielsen FS, Rossing P, Mandrup-Poulsen T, Osterby R, Nerup J. Parving HH, et al. Among authors: rossing p. Diabetes Care. 1999 Mar;22(3):478-83. doi: 10.2337/diacare.22.3.478. Diabetes Care. 1999. PMID: 10097932 Clinical Trial.

6

Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.

Tarnow L, Sato A, Ali S, Rossing P, Nielsen FS, Parving HH. Tarnow L, et al. Among authors: rossing p. Diabetes Care. 1999 Mar;22(3):491-4. doi: 10.2337/diacare.22.3.491. Diabetes Care. 1999. PMID: 10097934 Clinical Trial.

7

Remission of nephrotic-range albuminuria in type 1 diabetic patients.

Hovind P, Rossing P, Tarnow L, Toft H, Parving J, Parving HH. Hovind P, et al. Among authors: rossing p. Diabetes Care. 2001 Nov;24(11):1972-7. doi: 10.2337/diacare.24.11.1972. Diabetes Care. 2001. PMID: 11679467

8

Smoking and progression of diabetic nephropathy in type 1 diabetes.

Hovind P, Rossing P, Tarnow L, Parving HH. Hovind P, et al. Among authors: rossing p. Diabetes Care. 2003 Mar;26(3):911-6. doi: 10.2337/diacare.26.3.911. Diabetes Care. 2003. PMID: 12610058

9

Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH. Hovind P, et al. Among authors: rossing k, rossing p. Diabetes Care. 2003 Apr;26(4):1258-64. doi: 10.2337/diacare.26.4.1258. Diabetes Care. 2003. PMID: 12663607

10

Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

Andersen S, Tarnow L, Cambien F, Rossing P, Juhl TR, Deinum J, Parving HH. Andersen S, et al. Among authors: rossing p. Diabetes Care. 2003 May;26(5):1501-6. doi: 10.2337/diacare.26.5.1501. Diabetes Care. 2003. PMID: 12716812

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

786 results

Search Page

Filters